Death Row Prisoners Sue FDA Over Thiopental Imports
The FDA must deny admission to any drug, such as sodium thiopental, that is unapproved, misbranded or adulterated, according to the complaint, lodged in the U.S. District Court for the District of Columbia.
“Administering imported thiopental greatly increases the risk that plaintiffs will not be properly anesthetized,” the suit said. “That risk has...
To view the full article, register now.